Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 230 results for "Acute Myeloid Leukemia (AML)".

Thumbnail for Can Menin Inhibitors Bridge Patients to Transplant? Response Depth, MRD Negativity, and Differentiation Syndrome in NPM1-Mutated and KMT2A-Rearranged Acute Myeloid Leukemia

AML - 954

Can Menin Inhibitors Bridge Patients to Transplant? Response Depth, MRD Negativity, and Differentiation Syndrome in NPM1-Mutated and KMT2A-Rearranged Acute Myeloid Leukemia

Fnu Ashvin Rajeev Pillai

Poster Presenter: Fnu Ashvin Rajeev Pillai

Thumbnail for CDK4/6 Inhibitor Use and Risk of Therapy-Related Myeloid Neoplasms Following Chemotherapy for HR+/HER2- Breast Cancer: A Landmark Competing Risks Analysis

AML - 961

CDK4/6 Inhibitor Use and Risk of Therapy-Related Myeloid Neoplasms Following Chemotherapy for HR+/HER2- Breast Cancer: A Landmark Competing Risks Analysis

Jacqueline T Nguyen

Poster Presenter: Jacqueline T Nguyen

Previous 1...23 24 25 26 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for MRD-Adjusted Therapeutic Index of Menin Inhibitors in NPM1-Mutated and KMT2A-Rearranged Acute Myeloid Leukemia: A Genotype-Stratified Systematic Review and Meta-Analysis

AML - 971

MRD-Adjusted Therapeutic Index of Menin Inhibitors in NPM1-Mutated and KMT2A-Rearranged Acute Myeloid Leukemia: A Genotype-Stratified Systematic Review and Meta-Analysis

Sai Mourya Meda

Poster Presenter: Sai Mourya Meda

Thumbnail for Venetoclax-Azacitidine Versus Intensive Chemotherapy for Induction in Childhood Acute Myeloid Leukemia: A Comparative Analysis

AML - 993

Venetoclax-Azacitidine Versus Intensive Chemotherapy for Induction in Childhood Acute Myeloid Leukemia: A Comparative Analysis

Shyam Srinivasan

Poster Presenter: Shyam Srinivasan

Thumbnail for Outcomes of Consolidative Allogeneic Transplantation After Venetoclax Plus Hypomethylating Agent Induction in Acute Myeloid Leukemia: A Single-Center Retrospective Study

AML - 998

Outcomes of Consolidative Allogeneic Transplantation After Venetoclax Plus Hypomethylating Agent Induction in Acute Myeloid Leukemia: A Single-Center Retrospective Study

Milvyd? Tamutyt?-Jankausk?

Poster Presenter: Milvyd? Tamutyt?-Jankausk?

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors